In the news ShapeTX in the News Company News Media Mentions Blog Company News See All November 3, 2025 Shape Therapeutics Shares Breakthrough Preclinical Data for Non-Invasive Treatment of Parkinson’s Disease Using a Brain Targeted AAV Gene Therapy at the European Society of Gene & Cell Therapy 32nd Annual Congress September 26, 2025 Shape Therapeutics Announces Multiple Oral Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress September 18, 2025 VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid Media Mentions See All 23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022) Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022) Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022) Blog See All Spotlight Video: Dr. Adrian Briggs’ Next Scientific Puzzle Spotlight Video: Where Science and Art Collide How AI will revolutionize drug discovery: ShapeTX CEO Francois Vigneault on Tech Nation Spotlight Video: Solving puzzles as a team Generative AI is creating the next generation of therapies: programmable medicine ShapeTX at ASGCT 2023: Programmable Medicine Takes Center Stage
